{
    "company_name": "IMUGENE LIMITED",
    "address": "Suite 12.01, 4-6 Bligh Street, SYDNEY, NSW, AUSTRALIA, 2000",
    "summary": "Biotechnology",
    "details": "Biotechnology",
    "website": "http://www.imugene.com",
    "stock_code": "IMU",
    "links": "['/mission-and-values', '/leadership-team', '/management-team', '/scientific-advisory-board', '/corporate-governance', '/technologies-introduction', '/allogeneic-car-t-cell-therapy', '/oncarlytics-cf33-cd19', '/oncolytic-virus', '/b-cell-immunotherapies', '/mimotopes', '/publications', '/clinical-pipeline', '/clinical-trials', 'https://imu.investorhub.com/welcome', 'https://imu.investorhub.com/announcements', '/analyst-coverage', '/investor-presentations', '/conference-presentations', '/annual-reports', '/media', '/videos', '/newsletters', '/target-market-determination', '/esg-reports', '/news', 'https://app.trinethire.com/companies/174747-imugene/jobs', '/contact', '/', '/mission-and-values', '/leadership-team', '/management-team', '/scientific-advisory-board', '/corporate-governance', '/technologies-introduction', '/allogeneic-car-t-cell-therapy', '/oncarlytics-cf33-cd19', '/oncolytic-virus', '/b-cell-immunotherapies', '/mimotopes', '/publications', '/clinical-pipeline', '/clinical-trials', 'https://imu.investorhub.com/welcome', 'https://imu.investorhub.com/announcements', '/analyst-coverage', '/investor-presentations', '/conference-presentations', '/annual-reports', '/media', '/videos', '/newsletters', '/target-market-determination', '/esg-reports', '/news', 'https://app.trinethire.com/companies/174747-imugene/jobs', '/contact', 'https://investorhub.imugene.com/welcome', '/oncarlytics-cf33-cd19', '/oncolytic-virus', '/b-cell-immunotherapies', '/b-cell-immunotherapies', '/clinical-pipeline', '/analyst-coverage', '/newsletters', '/leadership-team', 'https://twitter.com/TeamImugene', 'https://www.linkedin.com/company/imugene', 'https://www.youtube.com/channel/UCCE0hsHAQD6cK0-U8PfH4Eg', '#header', 'https://www.bdacmedia.com']",
    "images": "https://www.facebook.com/tr, //images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/df2137b3-d282-4339-b3ac-90650116518b/Imugene_Logo_RGB.png, , https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/915a7ac8-3da9-4d42-b7ef-65ac01311017/3.png, https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/08010ea1-9ebb-47b6-907d-62bf81e39bbd/Copy+of+Copy+of+onCARlytics_8.png, https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/8b329b19-ec7c-4a94-bcb4-cb95a8b060b1/Copy+of+Copy+of+CF33_5.png, https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/442720ef-808f-4583-b1f6-9a05bf989b71/Copy+of+B-Cell_6-3.png, https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/b8d5b9b3-bf2f-4209-bc18-5c4c6a71e816/Copy+of+B-Cell_6-4.png, https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/66761918-0ca8-4508-b397-82fd2495f314/GettyImages-1264101698.jpg, https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/eeeed4a5-2a0d-4355-bca0-3d65bb849faa/GettyImages-497412306+copy.jpg, https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/103064de-955a-43d8-b068-dfc6fd1bed5f/GettyImages-872191096.jpg",
    "company_logo_link": "https://images.squarespace-cdn.com/content/v1/5b63d41b3e2d09b1f56bf483/df2137b3-d282-4339-b3ac-90650116518b/Imugene_Logo_RGB.png"
}